Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Model Based on Resected Normal Liver Parenchymal Volume（RNLV）to Predict the Risk of Post-Hepatectomy Liver Failure (PHLF)

NCT06366048 is registered in ClinicalTrials.gov with National Natural Science Foundation of China as lead sponsor.

NCT NCT06366048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06366048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Model Based on Resected Normal Liver Parenchymal Volume（RNLV）to Predict the Risk of Post-Hepatectomy Liver Failure (PHLF)
Lead sponsor
National Natural Science Foundation of China
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2022
Completion date
December 31, 2026
Enrollment
1,600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

liver failure